Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Glaucoma Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Glaucoma Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Glaucoma Therapeutics Market, by Disease Indication, 2019-2029 (USD Billion)
1.2.4. Glaucoma Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Glaucoma Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Glaucoma Therapeutics Market Dynamics
3.1. Glaucoma Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising incidence of glaucoma
3.1.1.2. Increasing technological advancements
3.1.2. Market Challenges
3.1.2.1. Drug recalls by major players
3.1.3. Market Opportunities
3.1.3.1. Rising geriatric population
Chapter 4. Global Glaucoma Therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Glaucoma Therapeutics Market, by Drug Class
6.1. Market Snapshot
6.2. Global Glaucoma Therapeutics Market by Drug Class, Performance - Potential Analysis
6.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Glaucoma Therapeutics Market, Sub Segment Analysis
6.4.1. Beta Blockers
6.4.2. Prostaglandins Analogs
6.4.3. Alpha Adrenergic Agonists
6.4.4. Carbonic Anhydrase Inhibitors
6.4.5. Combination Drugs
Chapter 7. Global Glaucoma Therapeutics Market, by Disease Indication
7.1. Market Snapshot
7.2. Global Glaucoma Therapeutics Market by Disease Indication, Performance - Potential Analysis
7.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
7.4. Glaucoma Therapeutics Market, Sub Segment Analysis
7.4.1. Open Angle Glaucoma
7.4.2. Angle Closure Glaucoma
Chapter 8. Global Glaucoma Therapeutics Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Glaucoma Therapeutics Market by Distribution Channel, Performance - Potential Analysis
8.3. Global Glaucoma Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
8.4. Glaucoma Therapeutics Market, Sub Segment Analysis
8.4.1. Hospital Pharmacy
8.4.2. Retail Pharmacy
8.4.3. Online Pharmacy
Chapter 9. Global Glaucoma Therapeutics Market, Regional Analysis
9.1. Glaucoma Therapeutics Market, Regional Market Snapshot
9.2. North America Glaucoma Therapeutics Market
9.2.1. U.S. Glaucoma Therapeutics Market
9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
9.2.1.2. Disease Indication breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Glaucoma Therapeutics Market
9.3. Europe Glaucoma Therapeutics Market Snapshot
9.3.1. U.K. Glaucoma Therapeutics Market
9.3.2. Germany Glaucoma Therapeutics Market
9.3.3. France Glaucoma Therapeutics Market
9.3.4. Spain Glaucoma Therapeutics Market
9.3.5. Italy Glaucoma Therapeutics Market
9.3.6. Rest of Europe Glaucoma Therapeutics Market
9.4. Asia-Pacific Glaucoma Therapeutics Market Snapshot
9.4.1. China Glaucoma Therapeutics Market
9.4.2. India Glaucoma Therapeutics Market
9.4.3. Japan Glaucoma Therapeutics Market
9.4.4. Australia Glaucoma Therapeutics Market
9.4.5. South Korea Glaucoma Therapeutics Market
9.4.6. Rest of Asia Pacific Glaucoma Therapeutics Market
9.5. Latin America Glaucoma Therapeutics Market Snapshot
9.5.1. Brazil Glaucoma Therapeutics Market
9.5.2. Mexico Glaucoma Therapeutics Market
9.5.3. Rest of Latin America Glaucoma Therapeutics Market
9.6. Rest of The World Glaucoma Therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Deep Dive
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Allergan Plc
10.2.3. Merck & Co., Inc.
10.2.4. Akorn, Operating Company LLC
10.2.5. Bausch & Lomb Incorporated
10.2.6. Oculis S.A.
10.2.7. Teva Pharmaceuticals Industries Ltd
10.2.8. Alcon
10.2.9. Pfizer Inc
10.2.10. Nanodropper, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption